Rare diseases
Investigational molecules
Locations
Study of Pemigatinib for Patients with Recurrent or Metastatic Solid Tumors with FGFR Gene Alteration
FranceStudy on Oxaliplatin with Drug Combination for Patients with Advanced Peritoneal Metastasis from Colorectal Cancer
FranceStudy of DS-3939a for Patients with Advanced or Metastatic Solid Tumors
FranceStudy on Dostarlimab and Niraparib for Patients with Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma
FranceStudy of Pembrolizumab and Cabozantinib for Patients with Advanced Sarcomas: Undifferentiated Pleomorphic Sarcoma, Osteosarcoma, and Ewing Sarcoma
FranceStudy on Durvalumab and Tremelimumab for Patients with Kidney Cancer at Risk of Recurrence After Surgery
FranceStudy on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease
FranceStudy Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma
FranceStudy on Everolimus and Drug Combination for Children with Relapsed or Refractory Pediatric Cancer
FranceStudy of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors
FranceStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy
FranceStudy on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
